Stock Track | Organon Soars 5.16% in Pre-Market as Q3 Earnings Beat Estimates, Despite Lowered Revenue Guidance

Stock Track11-10

Organon & Co (OGN) stock is soaring 5.16% in pre-market trading on Monday following the release of its third-quarter earnings report. The company reported adjusted earnings per share of $1.01, surpassing the analysts' estimate of $0.94. Revenue for the quarter came in at $1.602 billion, also beating the expected $1.575 billion.

The strong quarterly performance was highlighted by a significant improvement in profitability. Organon's adjusted EBITDA margin rose to 32.3% from 29.0% in the same quarter last year, primarily due to a 14% reduction in non-GAAP operating expenses. The company's adjusted net income increased to $263 million, up from $226 million in the third quarter of 2024.

However, investors should note that Organon has revised its full-year 2025 revenue guidance downward. The company now expects revenue in the range of $6.2 billion to $6.25 billion, compared to its previous forecast of $6.28 billion to $6.38 billion. This adjustment implies a nominal revenue growth between -3.2% and -2.4% for the year. Despite this cautious outlook, the market appears to be responding positively to the company's ability to exceed quarterly expectations and improve profitability in a challenging environment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126104227?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126104227","market":"nz","top_or_hot":-1,"title":"Stock Track | Organon Soars 5.16% in Pre-Market as Q3 Earnings Beat Estimates, Despite Lowered Revenue Guidance","media":"Stock Track","content":"<p>Organon & Co (OGN) stock is soaring 5.16% in pre-market trading on Monday following the release of its third-quarter earnings report. The company reported adjusted earnings per share of $1.01, surpassing the analysts' estimate of $0.94. Revenue for the quarter came in at $1.602 billion, also beating the expected $1.575 billion.</p>\n\n<p>The strong quarterly performance was highlighted by a significant improvement in profitability. Organon's adjusted EBITDA margin rose to 32.3% from 29.0% in the same quarter last year, primarily due to a 14% reduction in non-GAAP operating expenses. The company's adjusted net income increased to $263 million, up from $226 million in the third quarter of 2024.</p>\n\n<p>However, investors should note that Organon has revised its full-year 2025 revenue guidance downward. The company now expects revenue in the range of $6.2 billion to $6.25 billion, compared to its previous forecast of $6.28 billion to $6.38 billion. This adjustment implies a nominal revenue growth between -3.2% and -2.4% for the year. Despite this cautious outlook, the market appears to be responding positively to the company's ability to exceed quarterly expectations and improve profitability in a challenging environment.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Organon Soars 5.16% in Pre-Market as Q3 Earnings Beat Estimates, Despite Lowered Revenue Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Organon Soars 5.16% in Pre-Market as Q3 Earnings Beat Estimates, Despite Lowered Revenue Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-10 22:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Organon & Co (OGN) stock is soaring 5.16% in pre-market trading on Monday following the release of its third-quarter earnings report. The company reported adjusted earnings per share of $1.01, surpassing the analysts' estimate of $0.94. Revenue for the quarter came in at $1.602 billion, also beating the expected $1.575 billion.</p>\n\n<p>The strong quarterly performance was highlighted by a significant improvement in profitability. Organon's adjusted EBITDA margin rose to 32.3% from 29.0% in the same quarter last year, primarily due to a 14% reduction in non-GAAP operating expenses. The company's adjusted net income increased to $263 million, up from $226 million in the third quarter of 2024.</p>\n\n<p>However, investors should note that Organon has revised its full-year 2025 revenue guidance downward. The company now expects revenue in the range of $6.2 billion to $6.25 billion, compared to its previous forecast of $6.28 billion to $6.38 billion. This adjustment implies a nominal revenue growth between -3.2% and -2.4% for the year. Despite this cautious outlook, the market appears to be responding positively to the company's ability to exceed quarterly expectations and improve profitability in a challenging environment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OGN","symbol_name":"Organon & Co","start_time":0,"source_url":"","article_id":"1126104227","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126104227","pubTimestamp":1762785231,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Organon & Co (OGN) stock is soaring 5.16% in pre-market trading on Monday following the release of its third-quarter earnings report. The company reported adjusted earnings per share of $1.01,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OGN":"Organon & Co"},"translate_title":"个股追踪|Organon盘前大涨5.16%，第三季度盈利超预期，尽管营收指引下调","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OGN":1},"content_text":"Organon & Co (OGN) stock is soaring 5.16% in pre-market trading on Monday following the release of its third-quarter earnings report. The company reported adjusted earnings per share of $1.01, surpassing the analysts' estimate of $0.94. Revenue for the quarter came in at $1.602 billion, also beating the expected $1.575 billion.\nThe strong quarterly performance was highlighted by a significant improvement in profitability. Organon's adjusted EBITDA margin rose to 32.3% from 29.0% in the same quarter last year, primarily due to a 14% reduction in non-GAAP operating expenses. The company's adjusted net income increased to $263 million, up from $226 million in the third quarter of 2024.\nHowever, investors should note that Organon has revised its full-year 2025 revenue guidance downward. The company now expects revenue in the range of $6.2 billion to $6.25 billion, compared to its previous forecast of $6.28 billion to $6.38 billion. This adjustment implies a nominal revenue growth between -3.2% and -2.4% for the year. Despite this cautious outlook, the market appears to be responding positively to the company's ability to exceed quarterly expectations and improve profitability in a challenging environment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126104227","isCrawlerRequest":true}